DiagnaMed Holdings Corp. engages in providing artificial intelligence (AI) healthcare solutions. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-11-08. The firm delivers technology solutions for the cleantech and life sciences industries, with a focus on hydrogen production and artificial intelligence (AI)-driven drug discovery and diagnostics. The firm is focused on the commercialization of two technologies, such as a proprietary electromagnetic heating technology enabling hydrogen production from petroleum reservoirs and natural hydrogen fields, and BRAIN AGE BRAIN HEALTH, a proprietary brain health AI platform for the healthcare market. Its Brain Tremor is an investigating technological application that monitors, collects and uses individual information to detect tremors, and measure cognitive and brain activity in patients with neurological disorders. BRAIN AGE Brain Health is a brain health AI platform that aims to predict and monitor brain age and provide actionable insights into mental health and neurodegenerative disorders.
DGNMF stock price ended at $0.08 on 金曜日, after rising 0.00%
On the latest trading day Jan 16, 2026, the stock price of DGNMF rose by 0.00%, climbing from $0.07 to $0.08. Throughout the session, the stock experienced a volatility of 14.29%, with prices fluctuating between a daily low of $0.07 and a high of $0.08. Alongside this price increase, trading volume also rose by 153.8K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 57.0K shares were traded, amounting to a market value of approximately $8.7M.